RBC
NVO

Romano Brothers & Co’s Novo Nordisk NVO Stock Holding History

Romano Brothers & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$851K Sell
17,746
-500
-3% -$21.5K 0.09% 190
2026
Q1 		$671K Sell
18,246
-15,990
-47% -$758K 0.08% 201
2025
Q4 		$1.74M Buy
34,236
+29,978
+704% +$1.53M 0.2% 117
2025
Q3 		$236K Sell
4,258
-625
-13% -$36.6K 0.03% 303
2025
Q2 		$337K Sell
4,883
-1,490
-23% -$101K 0.04% 259
2025
Q1 		$443K Buy
6,373
+45
+0.7% +$3.72K 0.06% 224
2024
Q4 		$544K Buy
6,328
+680
+12% +$73.5K 0.07% 205
2024
Q3 		$673K Buy
5,648
+20
+0.4% +$2.67K 0.08% 187
2024
Q2 		$803K Buy
5,628
+170
+3% +$22.5K 0.11% 168
2024
Q1 		$701K Sell
5,458
-160
-3% -$19K 0.1% 180
2023
Q4 		$581K Sell
5,618
-760
-12% -$75.2K 0.09% 184
2023
Q3 		$580K Buy
6,378
+650
+11% +$57.3K 0.09% 185
2023
Q2 		$463K Buy
5,728
+208
+4% +$17K 0.07% 214
2023
Q1 		$439K Buy
5,520
+2,170
+65% +$154K 0.07% 220
2022
Q4 		$227K Buy
+3,350
New +$196K 0.03% 282

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Romano Brothers & Co's NVO Position: Q2 2026 in Review

Romano Brothers & Co reduced its Novo Nordisk (NVO) stake by 2.7% in Q2 2026, selling an estimated $21.5K and leaving 17,746 shares worth $851K. The position accounts for 0.09% of the portfolio, ranked #190.

Romano Brothers & Co first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.74M in Q4 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Romano Brothers & Co held 17,746 shares of Novo Nordisk worth $851K as of Q2 2026.
  • Romano Brothers & Co sold 500 Novo Nordisk shares in Q2 2026, an estimated $21.5K.
  • Novo Nordisk made up 0.09% of Romano Brothers & Co's portfolio in Q2 2026, its #190 holding.
  • Romano Brothers & Co first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
  • Romano Brothers & Co's Novo Nordisk position peaked at $1.74M in Q4 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.